Two different regimens of enoxaparin (40 mg once daily or 30 mg bid) have been used as control arms in trials of new oral anticoagulants. The choice of enoxaparin comparator may influence the perceived relative efficacy and safety of the newer agents, and we aimed to identify any significant differences between the two enoxaparin regimens.
- Administration, Oral
- Arthroplasty, Replacement, Hip
- Arthroplasty, Replacement, Knee
- Randomized Controlled Trials as Topic
- Venous Thromboembolism